《大行報告》瑞信下調阿里-SW(09988.HK)目標價至147元 評級「跑贏大市」
瑞信發表研究報告指,由於疫情反彈,預計阿里-SW(09988.HK)截至9月底止次財季收入按年增長3%至2,070億元人民幣(下同),料調整後EBITA錄332億元,較市場預期高出13%。該行認為,成本控制帶來的持續強勁盈利尚未反映在市場預測。該行指出,雖然仍然存在不確定因素,但與同行相比,阿里巴巴的市場份額損失正在緩和,亦有較大的成本優化空間。另外,其盈利亦因利潤率上升而恢復增長。
該行重申阿里巴巴為行業首選,惟預期短期內集團股價更多是受到內地市場情緒所影響,而非基本面的帶動。該行將其2023至2025各財年盈測上調2%至3%,將港股目標價161港元下調至147港元,評級「跑贏大市」。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.